BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lv H, Wu NC, Tsang OT, Yuan M, Perera RAPM, Leung WS, So RTY, Chan JMC, Yip GK, Chik TSH, Wang Y, Choi CYC, Lin Y, Ng WW, Zhao J, Poon LLM, Peiris JSM, Wilson IA, Mok CKP. Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections. bioRxiv 2020:2020. [PMID: 32511317 DOI: 10.1101/2020.03.15.993097] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 22.5] [Reference Citation Analysis]
Number Citing Articles
1 Al-Beltagi M, Saeed NK, Bediwy AS. COVID-19 disease and autoimmune disorders: A mutual pathway. World J Methodol 2022; 12(4): 200-223 [DOI: 10.5662/wjm.v12.i4.200] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
2 Kia V, Tafti A, Paryan M, Mohammadi-Yeganeh S. Evaluation of real-time NASBA assay for the detection of SARS-CoV-2 compared with real-time PCR. Ir J Med Sci 2022. [PMID: 35668337 DOI: 10.1007/s11845-022-03046-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Benabdessalem C, Marzouki S, Hamouda WB, Trabelsi K, Boumaiza M, Hamouda SB, Ouni R, Bchiri S, Chaaban A, Gdoura M, Gorgi Y, Sfar I, Yalaoui S, Khelil JB, Hamzaoui A, Abdallah M, Cherif Y, Petres S, Pun Mok CK, Escriou N, Quesney S, Dellagi K, Bettaieb J, Rourou S, Barbouche MR, Ahmed MB. COVID-19 in Tunisia (North Africa): IgG and IgG subclass antibody responses to SARS-CoV-2 according to disease severity.. [DOI: 10.1101/2022.03.01.22271696] [Reference Citation Analysis]
4 Ordoñez-jiménez F, Blanco-rodríguez R, Almocera AES, Chinney-herrera G, Hernández-vargas E. Quantifying antibody dynamics of severe and non-severe patients with COVID-19.. [DOI: 10.1101/2022.02.23.22271403] [Reference Citation Analysis]
5 Tut G, Lancaster T, Butler MS, Sylla P, Spalkova E, Bone D, Kaur N, Bentley C, Amin U, Jadir AT, Hulme S, Ayodel M, Dowell AC, Pearce H, Margielewska-davies S, Verma K, Nicol S, Begum J, Blakeway D, Jinks E, Tut E, Bruton R, Krutikov M, Shrotri M, Giddings R, Azmi B, Fuller C, Irwin-singer A, Hayward A, Copas A, Shallcross L, Moss P. Robust SARS-CoV-2-specific and heterologous immune responses after natural infection in elderly residents of Long-Term Care Facilities.. [DOI: 10.1101/2021.08.13.21261889] [Reference Citation Analysis]
6 Thakur N, Sood R. Current Diagnostic Approach for COVID ‐19. Detection and Analysis of SARS Coronavirus 2021. [DOI: 10.1002/9783527832521.ch1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bhattacherjee P, Patra S, Mishra A, Das TR, Dewangan H, Ghosh R, Shukla SK, Mishra A. COVID ‐19 Diagnostics: Current Approach, Challenges, and Technology Adaptation. Detection and Analysis of SARS Coronavirus 2021. [DOI: 10.1002/9783527832521.ch2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 He W, Yuan M, Callaghan S, Musharrafieh R, Song G, Silva M, Beutler N, Lee W, Yong P, Torres J, Melo M, Zhou P, Zhao F, Zhu X, Peng L, Huang D, Anzanello F, Ricketts J, Parren M, Garcia E, Ferguson M, Rinaldi W, Rawlings SA, Nemazee D, Smith DM, Briney B, Safonova Y, Rogers TF, Crotty S, Irvine DJ, Ward AB, Wilson IA, Burton DR, Andrabi R. Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaques.. [DOI: 10.1101/2021.07.05.451222] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
9 Bell BN, Powell AE, Rodriguez C, Cochran JR, Kim PS. Neutralizing antibodies targeting the SARS-CoV-2 receptor binding domain isolated from a naïve human antibody library.. [DOI: 10.1101/2021.01.07.425806] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Sil BK, Adnan N, Oishee MJ, Ali T, Jahan N, Khandker SS, Kobatake E, Mie M, Khondoker MU, Haq MA, Jamiruddin MR. Development and Evaluation of Two Rapid Indigenous IgG-ELISA immobilized with ACE-2 Binding Peptides for Detection Neutralizing Antibodies Against SARS-CoV-2.. [DOI: 10.1101/2020.12.19.20248535] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Piec I, English E, Thomas MA, Dervisevic S, Fraser WD, John WG. Performance of SARS-CoV-2 Serology tests: Are they good enough?. [DOI: 10.1101/2020.11.13.20229625] [Reference Citation Analysis]
12 Dogan M, Kozhaya L, Placek L, Gunter CL, Yigit M, Hardy R, Plassmeyer M, Coatney P, Lillard K, Bukhari Z, Kleinberg M, Hayes C, Arditi M, Klapper E, Merin N, Liang BT, Gupta R, Alpan O, Unutmaz D. Novel SARS-CoV-2 specific antibody and neutralization assays reveal wide range of humoral immune response during COVID-19. medRxiv 2020:2020. [PMID: 32676617 DOI: 10.1101/2020.07.07.20148106] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
13 Nielsen SS, Vibholm LK, Monrad I, Olesen R, Frattari GS, Pahus MH, Højen JF, Gunst JD, Erikstrup C, Holleufer A, Hartmann R, Østergaard L, Søgaard OS, Schleimann MH, Tolstrup M. SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity.. [DOI: 10.1101/2020.10.08.331645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Dyrdak R, Hodcroft EB, Wahlund M, Neher RA, Albert J. Interactions between seasonal human coronaviruses and implications for the SARS-CoV-2 pandemic: A retrospective study in Stockholm, Sweden, 2009-2020.. [DOI: 10.1101/2020.10.01.20205096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Zheng Y, Larragoite ET, Lama J, Cisneros I, Delgado JC, Slev P, Rychert J, Innis EA, Williams ESCP, Coiras M, Rondina MT, Spivak AM, Planelles V. Neutralization Assay with SARS-CoV-1 and SARS-CoV-2 Spike Pseudotyped Murine Leukemia Virions. bioRxiv 2020:2020. [PMID: 32995778 DOI: 10.1101/2020.07.17.207563] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Zeng C, Evans JP, Pearson R, Qu P, Zheng Y, Robinson RT, Hall-stoodley L, Yount J, Pannu S, Mallampalli RK, Saif L, Oltz E, Lozanski G, Liu S. Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers and convalescent plasma donors: a cohort study using a rapid and sensitive high-throughput neutralization assay.. [DOI: 10.1101/2020.08.02.20166819] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
17 Ryder SP, Morgan BR, Massi F. Analysis of Rapidly Emerging Variants in Structured Regions of the SARS-CoV-2 Genome. bioRxiv 2020:2020. [PMID: 32577650 DOI: 10.1101/2020.05.27.120105] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Premkumar L, Segovia-Chumbez B, Jadi R, Martinez DR, Raut R, Markmann A, Cornaby C, Bartelt L, Weiss S, Park Y, Edwards CE, Weimer E, Scherer EM, Roupael N, Edupuganti S, Weiskopf D, Tse LV, Hou YJ, Margolis D, Sette A, Collins MH, Schmitz J, Baric RS, de Silva AM. The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus Antibodies. medRxiv 2020:2020. [PMID: 32511572 DOI: 10.1101/2020.05.06.20093377] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
19 Udugama B, Kadhiresan P, Kozlowski HN, Malekjahani A, Osborne M, Li VYC, Chen H, Mubareka S, Gubbay JB, Chan WCW. Diagnosing COVID-19: The Disease and Tools for Detection. ACS Nano 2020;14:3822-35. [PMID: 32223179 DOI: 10.1021/acsnano.0c02624] [Cited by in Crossref: 996] [Cited by in F6Publishing: 1052] [Article Influence: 498.0] [Reference Citation Analysis]
20 Zhu Y, Yu D, Han Y, Yan H, Chong H, Ren L, Wang J, Li T, He Y. Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals.. [DOI: 10.1101/2020.04.20.052126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Lon JR, Bai Y, Zhong B, Cai F, Du H. Prediction and Evolution of B Cell Epitopes of Surface Protein in SARS-CoV-2.. [DOI: 10.1101/2020.04.03.022723] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 [DOI: 10.1101/2020.08.21.261727] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
23 [DOI: 10.1101/2020.04.10.20053207] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Reference Citation Analysis]
24 [DOI: 10.1101/2020.04.20.051219] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Reference Citation Analysis]
25 [DOI: 10.1101/2020.03.30.015461] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
26 [DOI: 10.1101/2020.10.20.346916] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Reference Citation Analysis]